Details
Title
Author Correction: Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Author
Galstyan, Anna 1 ; Markman, Janet L 1
; Shatalova, Ekaterina S 1 ; Chiechi Antonella 1 ; Korman, Alan J 2 ; Patil Rameshwar 1
; Klymyshyn Dmytro 1 ; Tourtellotte, Warren G 3 ; Israel, Liron L 1 ; Braubach Oliver 1
; Ljubimov, Vladimir A 1 ; Mashouf, Leila A 4 ; Ramesh Arshia 5 ; Grodzinski, Zachary B 1 ; Penichet, Manuel L 6 ; Black, Keith L 1 ; Holler Eggehard 7
; Sun, Tao 1 ; Ding, Hui 1 ; Ljubimov, Alexander V 8 ; Ljubimova, Julia Y 9
1 Cedars-Sinai Medical Center, Nanomedicine Research Center, Department of Neurosurgery, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
2 Bristol-Myers Squibb, Redwood City, USA (GRID:grid.419971.3)
3 Cedars-Sinai Medical Center, Department of Pathology and Laboratory Medicine, West Hollywood, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Cedars-Sinai Medical Center, Department of Biomedical Sciences, Board of Governors Regenerative Medicine Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
4 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
5 University of California, Los Angeles (UCLA), Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
6 David Geffen School of Medicine at University of California, Los Angeles (UCLA), Division of Surgical Oncology, Department of Surgery, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine at University of California, Los Angeles (UCLA), Department of Microbiology, Immunology and Molecular Genetics, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Los Angeles (UCLA), Jonsson Comprehensive Cancer Center, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Los Angeles (UCLA), The Molecular Biology Institute, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); of California, Los Angeles (UCLA), AIDS Institute, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Los Angeles (UCLA), The California NanoSystems Institute, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
7 Cedars-Sinai Medical Center, Nanomedicine Research Center, Department of Neurosurgery, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Universität Regensburg, Institut für Biophysik und Physikalische Biochemie, Regensburg, Germany (GRID:grid.7727.5) (ISNI:0000 0001 2190 5763)
8 Cedars-Sinai Medical Center, Department of Biomedical Sciences, Board of Governors Regenerative Medicine Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
9 Cedars-Sinai Medical Center, Nanomedicine Research Center, Department of Neurosurgery, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
; Shatalova, Ekaterina S 1 ; Chiechi Antonella 1 ; Korman, Alan J 2 ; Patil Rameshwar 1
; Klymyshyn Dmytro 1 ; Tourtellotte, Warren G 3 ; Israel, Liron L 1 ; Braubach Oliver 1
; Ljubimov, Vladimir A 1 ; Mashouf, Leila A 4 ; Ramesh Arshia 5 ; Grodzinski, Zachary B 1 ; Penichet, Manuel L 6 ; Black, Keith L 1 ; Holler Eggehard 7
; Sun, Tao 1 ; Ding, Hui 1 ; Ljubimov, Alexander V 8 ; Ljubimova, Julia Y 9 1 Cedars-Sinai Medical Center, Nanomedicine Research Center, Department of Neurosurgery, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
2 Bristol-Myers Squibb, Redwood City, USA (GRID:grid.419971.3)
3 Cedars-Sinai Medical Center, Department of Pathology and Laboratory Medicine, West Hollywood, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Cedars-Sinai Medical Center, Department of Biomedical Sciences, Board of Governors Regenerative Medicine Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
4 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
5 University of California, Los Angeles (UCLA), Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
6 David Geffen School of Medicine at University of California, Los Angeles (UCLA), Division of Surgical Oncology, Department of Surgery, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine at University of California, Los Angeles (UCLA), Department of Microbiology, Immunology and Molecular Genetics, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Los Angeles (UCLA), Jonsson Comprehensive Cancer Center, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Los Angeles (UCLA), The Molecular Biology Institute, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); of California, Los Angeles (UCLA), AIDS Institute, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Los Angeles (UCLA), The California NanoSystems Institute, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
7 Cedars-Sinai Medical Center, Nanomedicine Research Center, Department of Neurosurgery, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Universität Regensburg, Institut für Biophysik und Physikalische Biochemie, Regensburg, Germany (GRID:grid.7727.5) (ISNI:0000 0001 2190 5763)
8 Cedars-Sinai Medical Center, Department of Biomedical Sciences, Board of Governors Regenerative Medicine Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
9 Cedars-Sinai Medical Center, Nanomedicine Research Center, Department of Neurosurgery, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)
Publication year
2020
Publication date
2020
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2348777425
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.